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We show human herpesvirus 8 with diverse molecu-
lar subtype D variants to be highly endemic among the Ni-
Vanuatu population. Most K1 genes were nearly identical to 
Polynesian strains, although a few clustered with Australian 
or Taiwanese strains. These results suggest diverse origins 
of the Ni-Vanuatu population and raise questions about the 
ancient human population movements in Melanesia. 
H
uman herpesvirus 8 (HHV-8), or Kaposi Sarcoma As-
sociated Herpesvirus (KSHV), is the etiologic agent 
of Kaposi sarcoma (KS). HHV-8 is not a widespread ubiq-
uitous virus; its presence is mainly restricted to areas where 
classic or endemic KS is highly prevalent, i.e., estimates 
of HHV-8 seroprevalence in the general adult population 
range from 5% to >50% (1).
Exploiting the highly genetic variability of the HHV-8 
K1 gene, molecular epidemiology led to the identiﬁ  cation 
of 5 major K1 subtypes (A–E), some of which appear to 
be strongly linked to the geographic origin of the samples. 
Thus, the few known subtype D strains have been reported 
only in inhabitants from the Western Paciﬁ  c region (2).
For people of Oceanian ancestry (including Mela-
nesian, Polynesian, and Micronesian), very little data are 
available on the clinical and molecular epidemiology of 
HHV-8 and its associated diseases (3–9). Thus, we stud-
ied HHV-8 in the Vanuatu, an archipelago in the South-
west Paciﬁ  c region, formerly named New Hebrides, which 
contains >80 islands (6 provinces) (Figure 1). Indigenous 
Melanesians, also called Ni-Vanuatu, constitute 98% of the 
current population of ≈210,000. A recent study suggested 
that HHV-8 was rare in the Ni-Vanuatu population (10). 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 11, November 2007  1745 
*Institut Pasteur de Nouvelle-Calédonie, Nouméa, France; †Insti-
tut Pasteur, Paris, France; ‡ Institut National de la Santé et de la 
Recherche Médicale USSO, Paris, France; §World Health Orga-
nization/Organisation Mondiale de la Santé, Port-Vila, Republic of 
Vanuatu; and ¶Ministry of Health, Port-Vila, Republic of Vanuatu 
Figure 1. A) Age-dependent herpesvirus 8 (HHV-8) seroprevalence 
rates in 376 Ni-Vanuatu persons >65 years and living in 18 islands 
representative of the 6 provinces of the Vanuatu Archipelago. 
Seropositivity was based on strict criteria, and only samples clearly 
reactive at a dilution >1:160 were considered HHV-8 positive. B) 
Age-dependent HHV-8 seroprevalence rate in 283 Ni-Vanuatu 
persons from 13 families originating from 4 islands (3 from Loh, 
2 from Tanna, 4 from Ambae, and 4 from Esperitu Santo) of the 
Vanuatu archipelago. Error bars indicate 95% conﬁ  dence intervals 
C) Pedigrees of 2 families from Loh Island in which the presence 
of HHV-8 was examined in members of 3 generations. Gray circles 
and squares denote infected women and men, respectively. Black 
circles denote infected women for whom sequence of K1 gene 
fragment was obtained. Numbers within circles and squares 
indicate ages of the patients; NT, not tested.  DISPATCHES
Our goal for this cross-sectional study was to evaluate the 
prevalence of HHV-8 in the Vanuatu archipelago by using 
stringent serologic criteria and to characterize its genetic 
diversity.
The Study 
Our work was performed on a large collection of 
≈4,500 plasma and peripheral blood buffy coat (PBBC) 
samples from different islands of the archipelago, obtained 
in the framework of our previous studies on human T-cell 
lymphotropic virus (HTLV-1) (11,12). The ﬁ  eld survey, 
carried out from April 2003 through August 2005, has been 
extensively described (11). 
To detect plasma HHV-8 antibodies, an inhouse im-
munoﬂ  uorescence assay (IFA) using BC-3 cells express-
ing only latent-associated nuclear antigens encoded by 
ORF73, was performed to detect plasma HHV-8 antibod-
ies (13). Because HHV-8 seroprevalence increases with 
age in a virus-endemic population, we ﬁ  rst tested a series 
of 376 samples, from persons >65 years of age (mean 72, 
median 70, range 65–96 years; 182 men and 194 women) 
originating from the 6 provinces of the archipelago (on-
line Appendix Figure, available from www.cdc.gov/EID/
content/13/11/1745-appG.htm). Among these 376 plasma 
samples, 170 (45.2%) were IFA positive at a 1:160 dilution, 
showing a clear typical nuclear spotted seroreactivity. The 
HHV-8 seroprevalence was similar between men (45.6%) 
and women (44.8%). The prevalence of HHV-8 increased 
with age, rising from 29.6% (65–69 years) to 57.1% (>80 
years) (Figure 1, panel A) (p = 0.0005 trend χ2 test). This 
high level of HHV-8 seroprevalence was present in all 6 
provinces (online Appendix Figure). 
A second serologic survey that used 237 plasma 
samples taken from 13 families with genealogic trees was 
performed (Figure 1, panels B and C). Among these 237 
samples, 12 originated from elderly persons included in 
the 376 samples tested before. The HHV-8 seroprevalence 
was clearly age-dependent, rising from 6.9% among chil-
dren 1–9 years of age to 28.2% in adults 50 years of age, 
followed by a new increase in persons >51 years of age 
(55.9%) (p<10–4 trend χ2 test). These results demonstrate 
that HHV-8 infection is endemic, widespread, and circu-
lates in the Ni-Vanuatu population.
We then characterized these HHV-8 strains molecu-
larly. All DNA samples (1 μg), extracted from the PBBC, 
were ﬁ  rst ampliﬁ  ed by PCR for human β-globin sequences 
to control ampliﬁ  ability. HHV-8 infection was determined 
by a nested PCR to obtain a 737-bp fragment of the open 
reading frame of the K1 gene (ORFK1). The ﬁ  rst PCR was 
performed with the primer set K1AG75S/K1AG1200AS 
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Figure 2. Unrooted phylogenetic tree 
generated by the neighbor joining (NJ) 
method with a 624-bp fragment of the K1 
gene. The phylogeny was derived by the 
NJ method by using the GTR model in the 
PAUP program version 4.0b10 (Sinauer 
Associates, Sunderland, MA, USA). 
Reliability of the inferred tree was evaluated 
by bootstrap analysis on 1,000 replicates. 
Branch lengths are drawn to scale, with 
the bar indicating 0.1-nt replacement per 
site. Numbers on each node indicate the 
percentage of bootstrap samples (1,000) 
in which the cluster is supported. Only 
bootstrap values >75 are given. Not all 
samples have been labeled because of 
space constraints. The 30 new ORFK1 
HHV-8 sequences (GenBank accession 
nos. EF589742–EF589771) were analyzed 
with 195 HHV-8 available sequences from 
the GenBank database. Herpesvirus 8 Subtype D, Melanesia   
(14) and followed by a nested PCR with a second set of 
primers VR1S/VR2AS1 (15). All PCR products were pu-
riﬁ  ed from gel, cloned, and sequenced. Sequences were 
veriﬁ  ed on both DNA strands. ORFK1 ampliﬁ  cation was 
obtained from 32 (21.6%) of the 148 HHV-8–seropositive 
samples tested but in none of the 26 HHV-8–seronegative 
samples. Sequences were obtained for only 30 of the 32 
ORFK1-positive PCRs (Table).
Comparative sequence analysis indicates that the 30 
new sequences differed from each other. Furthermore, 
among them, 3 groups can be clearly identiﬁ  ed. The ﬁ  rst 
group comprises most strains (23/30) and corresponds to 
the sequences found in persons from the south central is-
lands of the archipelago (Mallicolo, Ambrym, Epi, Ton-
goa, Emae, and Tanna); the second group comprises 4 se-
quences from persons living in the northern islands of Loh 
(LO13, LO17, LO48) and Santo (CESW32); and the third 
group involves only 3 sequences (ML10, ML36, ML46) 
from persons living in the northern island of Motalava.
Phylogenetic analyses were performed on the 30 nov-
el sequences obtained in this study, on all subtype D avail-
able K1 sequences, and on representatives of the different 
HHV-8 subtypes/subgroups, as described (4). The phylo-
genetic analyses were performed with all of the sequences 
available. These sequences include 3 strains from Japan 
(J24, J25, and J26), 1 from Australia (3Au1), 1 from Tai-
wan (TKS10), 1 from New Zealand (ZKS3), and 1 from 
Wallis (WalKS1) (2,4, 6–8). Our results demonstrate that 
the Ni-Vanuatu HHV-8 clustered in 3 different genotype 
D subclades, which are highly supported phylogenetically 
with high bootstrap values of 99% or 100% (Figure 2). 
The ﬁ  rst one comprising most strains corresponds to se-
quences closely related to each other and to the 2 Polyne-
sian strains WalKS1 and ZKS3 (4,8). The second group 
(Loh/Santo), with only 4 sequences, was closely related 
to the Taiwanese strain TKS10 (8). The last 3 sequences 
from Motalava were nearly identical to the only strain 
from Australia (6).
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Table. Demographic, geographic, and serologic data of HHV-8 seropositive persons from the Vanuatu Archipelago, confirmed by 
molecular analysis* 
Virus strain  Age, y  Sex Island of origin  Province
IFA titers 
(LANA) PCR K1  GenBank accession no. 
LO 17  70 F Loh TORBA 10.240 + EF589758
LO 13  23 F Loh TORBA 160 + EF589757
LO 48  64 F Loh TORBA 640 + EF589759
ML 10  60 F Mota Lava  TORBA 640 + EF589763
ML 36  60 M Mota Lava  TORBA 640 + EF589764
ML 46  61 M Mota Lava  TORBA 1.280 + EF589765
ES 65  82 F Santo SANMA 160 + EF589756
CES W32  60 F Santo SANMA 320 + EF589746
MA 55  60 F Maewo  PENAMA 2,560 + EF589760
MAL 4  74 M Mallicolo MALAMPA 320 + EF589761
MAL 24  70 M Mallicolo MALAMPA 1.280 + EF589762
RYM 31  80 F Ambrym  MALAMPA 40 + EF589766
RYM 42  74 F Ambrym  MALAMPA 80 + EF589767
EP 43  80 F Epi SHEFA 20.480 + EF589753
EP 58  79 F Epi SHEFA 20.480 + EF589754
EP 111  74 F Epi SHEFA 1,280 + EF589755
TON 72  75 M Tongoa SHEFA 5.120 + EF589772
CTON H54  71 M Tongoa SHEFA 2.560 + EF589747
EM 1  70 M Emae SHEFA 640 +†N A
EM 4  75 F Emae SHEFA 2.560 + EF589752
CEM H2  73 M Emae SHEFA 1.280 + EF589744
EF 43  73 F Efate SHEFA 640 + EF589748
EF 52  74 M Efate SHEFA 1.280 + EF589749
EF 55  81 M Efate SHEFA 640 + EF589750
EF 56  75 F Efate SHEFA 5.120 +†N A
EF 60  73 F Efate SHEFA 640 + EF589751
CEF H56  72 M Efate SHEFA 80 + EF589742
CEF H67  70 M Efate SHEFA 640 + EF589743
TA 115  77 M Tanna TAFEA 1.280 + EF589768
TA 116  70 F Tanna TAFEA 320 + EF589769
TA 124  70 F Tanna TAFEA 5.120 + EF589770
TA 162  70 M Tanna TAFEA 5.120 + EF589771
*IFA, immunofluorescence assay; LANA, HHV-8 specific antibody directed against latent nuclear antigen; PCR K1, PCR for amplification of a 737-bp 
fragment of the ORFK1 genomic region of HHV-8; NA, not available. 
†Weak PCR signal. DISPATCHES
Furthermore, phylogenetic analysis showed a star-like 
tree with a long branch for the Polynesian clade, which in-
cludes most Ni-Vanuatu strains. This ﬁ  nding strongly sug-
gests a common origin or ancestor for these strains, with a 
possible founder effect (Figure 2). Based on stringent sero-
logic and molecular analyses, our study demonstrates for 
the ﬁ  rst time, to our knowledge, that HHV-8 infection is 
endemic in a Melanesian population. 
Our serologic ﬁ  ndings are consistent with those found 
in some remote villages of Papua New Guinea (5,9). On the 
basis of these studies, it is tempting to suggest that intrafa-
milial HHV-8 transmission occurs in such populations, as 
previously demonstrated in highly HHV-8 endemic popu-
lations of African origin (13).
From the molecular point of view, ﬁ   nding such a 
high molecular diversity of HHV-8 subtype D with some 
Polynesian-, Taiwanese- and Australian-like strains was 
surprising. These heterogeneous ﬁ  ndings contrast with the 
more homogenous situation found for HTLV-1 genotypes 
in the same population (11).
Conclusions
Our molecular ﬁ  ndings suggest that HHV-8 has been 
introduced in the Ni-Vanuatu populations by different mi-
grations of infected persons. This conclusion is strength-
ened by the clustering of the Australian- and Taiwanese-
like strains in the northern islands of Loh and Motalava. A 
variety of scenarios have been proposed to explain the peo-
pling of near and remote Oceania, and our data highlight the 
possible multiple origins of Ni-Vanuatu ancestors. Ongoing 
molecular studies on both viral and mitochondrial/nuclear 
DNA will contribute to this debate through analyses of the 
variations observed. Indeed, these variations are intimately 
linked with the dispersal of early human settlers; analyses 
of the genetic variability of HHV-8 can help us reconstruct 
the patterns of human dispersal into Oceania (11).
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